Nasal Polyps: Symptoms, Causes, and Treatment Options

Dr. Steven Enrich, MD · Published October 4, 2026

By Dr. Steven Enrich, MD — Board-Certified Otolaryngologist

Related reading

Browse all gsc-strike articles.

Nasal polyps are noncancerous, soft growths that develop inside the nose or sinuses, typically caused by chronic inflammation or allergies. These benign polyps can range from small and asymptomatic to large enough to block airflow and impair quality of life. Nasal polyps affect approximately 4% of the population, according to medical literature, though they remain underdiagnosed in many cases. They occur in both children and adults, though adult cases are more common. When polyps grow large enough to obstruct the nasal passages or sinuses, they can trigger persistent congestion, sinus infections, breathing problems, and sleep disturbances. Understanding the causes, recognizing the symptoms early, and exploring treatment options—from medical management to surgical removal—helps patients regain normal breathing and sinus function.

Nasal polyps develop when the tissue lining the nose or paranasal sinuses becomes chronically inflamed and forms soft, grape-like growths. These growths are benign and do not become cancerous. The polyps typically originate near the opening of the maxillary sinuses or the ethmoid sinuses and can grow slowly over months or years. Small polyps may cause no symptoms, while larger polyps obstruct airflow, trap mucus, and trigger secondary sinus infections.

What Are Nasal Polyps and How Do They Develop?

Nasal polyps are soft, noncancerous growths that form inside the nasal passages or paranasal sinuses. Unlike skin polyps or colon polyps, nasal polyps feel spongy and move freely within the nasal cavity. They develop from the mucous membrane lining and typically appear in clusters, resembling small grapes or teardrops under endoscopic examination.

The exact mechanism behind nasal polyp formation remains incompletely understood, but chronic inflammation is the primary driver. When the tissue lining the nose or sinuses stays inflamed for extended periods—due to allergies, asthma, chronic rhinosinusitis, or recurrent infections—fluid accumulates within the mucous membrane, eventually forming polyps. Some polyps are unilateral (one-sided), while others develop bilaterally (both sides).

Key Risk Factors

Unlike in Western populations, nasal polyps in Asian populations show higher association with chronic rhinosinusitis but lower association with allergies, suggesting genetic and environmental variation in polyp etiology.

Symptoms and Signs of Nasal Polyps

Small nasal polyps often cause no symptoms and may be discovered incidentally during sinus imaging or nasal endoscopy for another reason. As polyps enlarge, they obstruct airflow and trigger progressive symptoms that worsen over weeks or months.

Common Symptoms

  1. Nasal congestion – persistent blockage, often unilateral at first, then bilateral
  2. Rhinorrhea – runny nose or postnasal drip from trapped secretions
  3. Facial pain or pressure – sensation of fullness in the face or forehead
  4. Hyposmia or anosmia – reduced or absent sense of smell
  5. Sleep-disordered breathing – snoring or obstructive sleep apnea (OSA)
  6. Recurrent sinus infections – polyps trap mucus, predisposing to bacterial sinusitis
  7. Mouth breathing – caused by nasal obstruction
  8. Headaches – often frontal or vertex, worsening with sinus pressure
  9. Ear fullness or otitis media – secondary to Eustachian tube obstruction

Parents may notice children with large polyps develop sleep apnea, fail to thrive, or experience chronic ear infections. In adults, the combination of anosmia and nasal obstruction lasting more than a few weeks warrants nasal endoscopic evaluation to rule out polyps or other structural causes. Importantly, many patients confuse nasal polyps with deviated septum symptoms; while both cause congestion, polyps are soft and movable, whereas a deviated septum is rigid bone or cartilage.

Why Do Nasal Polyps Form? Understanding the Underlying Causes

Nasal polyp formation results from chronic inflammatory states that alter the normal barrier function of the nasal mucosa. Unlike acute sinusitis (viral or bacterial infection), nasal polyps develop gradually over months to years as the underlying inflammatory process remodels tissue.

Allergic Rhinitis and Environmental Triggers

Allergies are among the most common co-conditions in patients with nasal polyps. Seasonal or perennial allergen exposure—such as pollen, dust mites, pet dander, or mold—activates Type 2 immune responses in the nose. This flooding of eosinophils and other inflammatory cells chronically irritates the mucosa, causing edema and polyp formation. Patients with poorly controlled allergic rhinitis often find that nasal steroid sprays reduce polyp size and prevent recurrence after removal.

Chronic Rhinosinusitis

Chronic rhinosinusitis (CRS) is the most strongly associated condition, present in up to 90% of polyp patients. CRS involves prolonged inflammation of the paranasal sinuses lasting beyond 12 weeks. The inflammatory milieu in CRS—characterized by abnormal mucus rheology, impaired mucociliary clearance, and dysregulated immune responses—predisposes epithelial tissue to undergo edematous remodeling and polyp formation.

Asthma

Patients with asthma, especially eosinophilic asthma or severe persistent asthma, have a 2-5 fold increased risk of developing nasal polyps. The shared Th2-mediated inflammation in both airways and nasal passages explains this association. Patients with concurrent asthma and nasal polyps often experience worse asthma control and higher exacerbation rates.

Cystic Fibrosis

Cystic fibrosis impairs chloride secretion in mucous glands, producing abnormally thick, viscous secretions throughout the respiratory tract. The inspissated mucus obstructs sinus drainage, leading to chronic sinus infection and, in nearly half of CF patients, nasal polyp formation. CF-associated polyps are often larger, more numerous, and more prone to recurrence after surgical removal.

Aspirin Sensitivity and NSAID Reaction

Samter syndrome (aspirin-exacerbated respiratory disease, AERD) combines chronic rhinosinusitis, nasal polyps, asthma, and reactions to NSAIDs and COX-1 inhibitors. The mechanism involves altered arachidonic acid metabolism, leading to excessive leukotriene production and eosinophilic inflammation. AERD patients require different management strategies, including leukotriene inhibitors and aspirin desensitization in specialized centers.

How Are Nasal Polyps Diagnosed?

Diagnosis of nasal polyps begins with a careful history and physical examination, followed by nasal endoscopy and imaging when indicated.

Clinical History and Physical Examination

Board-certified otolaryngologists ask patients about symptom onset, duration, severity, and associated triggers (allergies, asthma, previous infections). The clinician performs anterior rhinoscopy or uses a handheld otoscope to visualize the nasal vestibule, though larger polyps may be missed with this limited view.

Nasal Endoscopy

Flexible or rigid nasal endoscopy is the gold standard for polyp visualization. A thin, lighted scope allows direct visualization of the nasal cavity and nasopharynx, revealing polyp size, location (unilateral vs. bilateral), color (typically pale or grayish), and surface characteristics. Endoscopy also assesses for concurrent sinus involvement, drainage patterns, and signs of infection. Patients tolerate endoscopy well, especially with topical anesthesia and vasoconstriction.

Imaging Studies

Computed Tomography (CT) of the sinuses provides detailed anatomical information, particularly useful for: - Surgical planning when polyp removal is considered - Assessing the extent of sinus involvement - Excluding other diagnoses (tumors, fungal sinusitis, encephaloceles) - Identifying anatomical variations (Onodi cells, sphenoid sinus asymmetry) that affect surgical approach

CT findings typically show lobulated opacities within affected sinuses with possible bone remodeling from chronic mass effect.

Laboratory and Immunological Assessment

Allergy testing (skin prick or serum-specific IgE) identifies allergen triggers, guiding medical management. Sweat chloride testing is warranted in pediatric polyp cases to exclude cystic fibrosis. Testing for NSAID sensitivity and consideration of Samter syndrome criteria applies to patients with concurrent asthma and aspirin reactions.

Medical and Surgical Treatment Options for Nasal Polyps

Treatment of nasal polyps follows a stepwise approach, starting with medical management and progressing to surgical intervention if conservative measures fail.

Medical Management

Intranasal Corticosteroid Sprays

Intranasal corticosteroids (INCS) are the first-line medical therapy, shrinking polyp size and reducing inflammation. Common agents include fluticasone propionate, mometasone furoate, and beclomethasone. These topical steroids work locally with minimal systemic absorption. Studies show approximately 30-50% of patients achieve significant polyp size reduction with consistent INCS use over 3-6 months. Patients should be counseled on proper spray technique (aiming laterally, away from the nasal septum) to maximize drug deposition in polyp regions.

Saline Irrigation

Bidaily or thrice-daily saline irrigation (using neti pots or squeeze bottles) removes mucus, reduces postnasal drip, and aids clearance of inflammatory mediators. Many patients tolerate this as an adjunct to steroid therapy without side effects.

Allergy Management

Identifying and treating underlying allergies through allergen avoidance, antihistamines, or immunotherapy reduces inflammatory triggers and may prevent polyp recurrence after surgical removal.

Systemic Corticosteroids

Short courses of oral prednisone (typically 5-7 days) may reduce acute polyp-related obstruction and are sometimes used preoperatively to shrink polyps and reduce intraoperative bleeding. Long-term systemic steroids carry unacceptable side effects and are not recommended as maintenance therapy.

Biologic Therapies

Dupilumab, a monoclonal antibody targeting IL-4 receptor (reducing Th2 inflammation), has demonstrated efficacy in reducing nasal polyp burden in clinical trials, particularly for patients with concurrent asthma or eczema. Omalizumab (anti-IgE) and other biologics are under investigation.

Surgical Management: Endoscopic Sinus Surgery

When medical therapy fails to control symptoms or polyps recur frequently, endoscopic sinus surgery (ESS) offers definitive removal. Using an operating microscope or endoscope, the surgeon carefully identifies polyp attachments (typically near the maxillary sinus ostium or ethmoid sinuses) and removes them with instruments or powered microdebriders.

Key surgical principles: - Complete removal of the polyp stalk and base to reduce recurrence - Careful inspection of ethmoid cavities to remove secondary or satellite polyps - Preservation of normal mucosa and avoidance of aggressive removal that creates excessive scarring - Opening and ventilating obstructed sinuses to restore normal mucus clearance

Recurrence rates after ESS range from 10-30%, depending on underlying etiology, completeness of removal, and adherence to postoperative medical therapy. Patients with cystic fibrosis or Samter syndrome experience higher recurrence rates. Postoperative INCS spray and saline rinses significantly reduce polyp regrowth.

Benefits of early surgical intervention: - Restoration of olfaction (smell) in 70-80% of patients - Relief of nasal obstruction and sleep apnea - Reduction in recurrent sinus infections - Improved medication delivery to sinus cavities - Decreased postnasal drip and throat clearing

Balloon sinuplasty, a less invasive technique using dilating catheters to open sinus ostia, may complement traditional ESS but is typically used alongside polyp removal rather than as standalone therapy.

Living With Nasal Polyps: Prevention and Follow-Up Care

Successful management of nasal polyps extends beyond initial treatment to long-term surveillance and prevention strategies.

Postoperative Care After Polyp Removal

Following endoscopic sinus surgery, patients use saline rinses 2-3 times daily for 2-4 weeks to cleanse the surgical site, remove crusts, and reduce infection risk. Intranasal steroid sprays continue at full strength for several months, then typically taper to maintenance dosing. Endoscopic follow-up at 2-4 weeks postoperatively allows the surgeon to clear debris and assess healing. Patients should avoid strenuous activity and nasal trauma for 1-2 weeks.

Long-Term Medical Management

Continuing intranasal corticosteroid sprays after polyp removal is crucial to prevent recurrence. Many patients require indefinite INCS maintenance, especially those with allergic rhinitis or chronic rhinosinusitis. Compliance with this regimen substantially reduces polyp recurrence risk from 30% to 10% or less.

Allergen Control and Trigger Avoidance

Patients with allergic triggers should: - Use high-efficiency particulate air (HEPA) filters in bedrooms - Maintain humidity levels between 30-50% to discourage mold growth - Wash bedding weekly in hot water - Minimize pet exposure in sleeping areas - Use saline rinses after outdoor exposure during high pollen counts

Surveillance Imaging and Follow-Up

Clinicians typically schedule follow-up nasal endoscopy at 3-6 months postoperatively, then annually or as symptoms warrant. CT imaging is reserved for recurrent polyps, atypical presentations, or preoperative planning for revision surgery. Serial imaging without symptoms does not change management and increases unnecessary radiation exposure.

Special Considerations for Pediatric Patients

Children with nasal polyps warrant evaluation for cystic fibrosis, particularly if polyps present before age 5, are bilateral, or rapidly recur. Once CF is excluded, pediatric polyp management follows the same stepwise approach. Children often tolerate INCS well, and many experience spontaneous improvement with age as immune function matures.

Frequently Asked Questions

Are nasal polyps cancerous or dangerous?

No, nasal polyps are benign (noncancerous) growths and do not develop into cancer. They are soft, fluid-filled sacs that originate from the nasal mucosa. However, polyps can obstruct airflow, trap mucus, and trigger sinus infections, causing significant discomfort and sleep disturbance. Large polyps can impair sense of smell and quality of life. While not medically dangerous in themselves, their complications warrant evaluation and treatment. Rarely, a large growth in the nasal cavity that appears different from typical polyps should be biopsied to confirm benignity and exclude other pathology.

Can nasal polyps go away on their own without treatment?

Small, asymptomatic nasal polyps may remain stable for years or occasionally regress spontaneously, particularly if the underlying inflammatory trigger (allergies, chronic infection) is controlled. However, most polyps that cause symptoms do not resolve without intervention. Once established, polyps typically require medical management with intranasal steroid sprays or, for large obstructive polyps, surgical removal. Some patients experience temporary improvement with aggressive allergy treatment or a course of systemic corticosteroids, but relapse is common when treatment stops. Long-term follow-up ensures early detection of recurrence.

What is the recurrence rate after nasal polyp surgery?

Recurrence rates after endoscopic polyp removal range from 10-40%, depending on underlying cause, completeness of surgical removal, and adherence to postoperative medical therapy. Patients who use intranasal steroid sprays consistently after surgery experience significantly lower recurrence (10-15%) compared to those who discontinue sprays (30-40%). Patients with cystic fibrosis, Samter syndrome, or severe eosinophilic airway disease have higher recurrence rates (40-50%). Regular follow-up endoscopy and imaging help detect early recurrence before polyps cause severe obstruction.

Do intranasal steroid sprays actually shrink nasal polyps?

Yes, intranasal corticosteroid sprays reduce polyp size and symptoms in 30-50% of patients with mild to moderate polyps. Regular use over 3-6 months can produce measurable shrinkage on endoscopy and CT imaging. These sprays work by suppressing local inflammation and reducing eosinophil infiltration. Proper application technique is essential—patients should direct the spray nozzle laterally (away from the septum) to maximize drug deposition on the polyp surface. Intranasal steroids are safe for long-term use with minimal systemic absorption, making them the foundation of medical management.

Can cystic fibrosis cause nasal polyps?

Yes, cystic fibrosis is strongly associated with nasal polyps. Nearly 50% of CF patients develop nasal polyps due to abnormal mucus secretion and chronic sinus infection. CF polyps are often larger, more numerous, and more prone to recurrence than polyps in non-CF patients. Any child presenting with nasal polyps—especially before age 5 or with bilateral involvement—should undergo sweat chloride testing to exclude CF. CF-associated polyps may benefit from more aggressive medical management and surgical intervention to optimize sinus drainage and reduce infection risk in these patients, who are vulnerable to respiratory complications.

How do I know if I should have nasal polyp surgery?

Surgery is considered when nasal polyps cause significant symptoms uncontrolled by medical therapy (intranasal steroids, saline rinses, allergy management) for 3-6 months. Indications include severe nasal obstruction affecting sleep or daily function, recurrent sinus infections related to polyp-induced obstruction, loss of sense of smell, or sleep-disordered breathing. Board-certified otolaryngologists perform a shared decision-making discussion, reviewing the potential benefits (symptom relief, improved breathing and smell), risks (bleeding, infection, need for revision), and alternatives before surgery. A preoperative CT scan confirms polyp burden and guides surgical planning.

Conclusion

Nasal polyps are common, benign growths affecting millions of adults and some children, often triggered by chronic inflammation, allergies, or chronic sinus disease. While small polyps may cause no symptoms, larger polyps obstruct breathing, impair smell, and reduce quality of life. A stepwise treatment approach—starting with intranasal steroid sprays, saline irrigation, and allergy management—controls symptoms in many patients. For those who don't respond to medical therapy or experience recurrent polyps, endoscopic sinus surgery offers definitive removal with high success rates. Long-term use of intranasal steroids after surgery significantly reduces polyp recurrence.

If you experience persistent nasal congestion, loss of smell, facial pressure, or sleep disturbances lasting more than a few weeks, a board-certified otolaryngologist can perform nasal endoscopy to identify the cause. Early diagnosis and tailored treatment—whether medical or surgical—restore normal breathing and sinus function. For patients in the Nashville and Middle Tennessee area, experienced ENT specialists are available to evaluate nasal polyps, discuss all treatment options, and help you regain your quality of life. Schedule a consultation today to explore the approach that's right for your situation.

Sources